Impact Genetics provides cost-effective, high quality genetic testing for select diseases.
In collaboration with our leading scientists and clinical care providers, we continually refine tests to maximize sensitivity. New scientific discoveries, genetic data and clinical knowledge flow freely to maximize health impact. Impact Genetics’ service delivery team is committed to supporting doctors and genetic specialists with outstanding service.
April 4th, 2016 – Impact Genetics Tests Listed on LabCorp Test Menu. Impact Genetics’ uveal melanoma and HHT tests are now available to be ordered through LabCorp in the United States. More information.
Joan speaks about her decision to undergo prognostic UM tumor testing. This is followed by interviews with Dr. Tara McCannel (UCLA) and Dr. Bertil Damato (UCSF) who discuss how they use results of UM genetic testing and the importance of this testing to their patients.
We offer the following clinical genetic tests in our CAP/CLIA certified lab.
- Retinoblastoma (RB)
Highly sensitive genetic testing to inform clinical care of Retinoblastoma patients and their families. more
- Hereditary Hemorrhagic Telangiectasia (HHT)
Highly sensitive genetic testing to aid in HHT diagnosis and care of patients and families. more
- Uveal Melanoma (UM)
Most comprehensive genetic test to determine chance of survival without metastatic disease. more
Why choose us?
- Cost effective
- Documented high diagnostic sensitivity
- Provided by disease experts
- Flexible billing and personal support
- Quick turn-around times
- Comprehensive and informative reports
News and Events
An online live educational webinar. Wednesday, Oct 12th at 12:00pm. More information and to register.